Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
Funder
National Institutes of Health
LOI Deadline
;
;
LOI Required
Recommended, but not required
Application Deadline
;
;
Maximum Project Duration
5 years
Research Focus Areas
Digital Health/Mobile Technologies
Brain Stimulation Therapies/Neuromodulation (TMS, VNS, DBS, ECT)
Substance Use/Misuse/Addiction
Research Methods
Mobile Technologies/Other Digital Health
Randomized Trial Designs
Description
The purpose of this notice of funding opportunity (NOFO) is to accelerate the development of devices to treat Substance Use Disorders (SUDs). The continuing advances in technologies offer unprecedented opportunities to develop neuromodulatory or neurophysiological devices that are safe and effective SUD treatments. The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs.